HIGHLIGHTS   |  March 26, 2020   Young Women Diagnosed with Breast Cancer Likely to Experience Financial Decline A recent study found that young women aged 18-39 diagnosed with breast cancer typically suffer through financial hardships regardless of outstanding life circumstances such as career and insurance coverage. Read more   FDA Approves Nivolumab-Ipilimumab Combo for Hepatocellular Carcinoma The FDA approved the combination use of nivolumab plus ipilimumab for the treatment of patients with HCC who have been previously treated with sorafenib. Read more   In Case You Missed It

Study Highlights Importance of Progression-Related End Points in Cancer This study examined the association of disease progression and the deterioration of health-related quality of life for patients with metastatic breast, pancreatic, lung, and colorectal cancer. Read more